Ep. 162 - New CMS Payment Models, China Markets Outlook, & Zhang's Latest Start-Up

from BioCentury This Week · host BioCentury

On the latest BioCentury This Week podcast, BioCentury’s editors discuss what the latest payment models from CMS could mean for cell and gene therapies, and how a new model could incentivize the completion of confirmatory trials for drugs with accelerated approval. BioCentury's editors also discuss the outlook for China's public markets and details around the genetic medicine delivery technology of recently launched Aera Therapeutics.Reach us by sending a text

Episode metadata supplied by the publisher feed · Published Feb 21, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep. 162 - New CMS Payment Models, China Markets Outlook, & Zhang's Latest Start-Up

0:00 21:37

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioCentury This Week?

This episode is 21 minutes long.

When was this BioCentury This Week episode published?

This episode was published on February 21, 2023.

Can I download this BioCentury This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!